Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Aubrey Capital Management Ltd

Aubrey Capital Management Ltd lessened its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 38.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,100 shares of the biotechnology company’s stock after selling 5,800 shares during the period. Axon Enterprise comprises 2.0% of Aubrey Capital Management Ltd’s portfolio, making the stock its 10th largest holding. Aubrey Capital Management Ltd’s holdings in Axon Enterprise were worth $5,407,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of AXON. FSR Wealth Management Ltd. acquired a new position in Axon Enterprise during the fourth quarter worth approximately $238,000. Comprehensive Financial Planning Inc. PA acquired a new position in Axon Enterprise during the fourth quarter worth approximately $150,000. Savant Capital LLC increased its position in Axon Enterprise by 5.7% during the fourth quarter. Savant Capital LLC now owns 1,080 shares of the biotechnology company’s stock worth $642,000 after purchasing an additional 58 shares during the last quarter. Burns Matteson Capital Management LLC increased its position in Axon Enterprise by 3.4% during the fourth quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company’s stock worth $450,000 after purchasing an additional 25 shares during the last quarter. Finally, Kestra Private Wealth Services LLC increased its position in Axon Enterprise by 44.6% during the fourth quarter. Kestra Private Wealth Services LLC now owns 14,420 shares of the biotechnology company’s stock worth $8,570,000 after purchasing an additional 4,449 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Up 0.3 %

NASDAQ AXON opened at $679.24 on Monday. Axon Enterprise, Inc. has a 12 month low of $255.68 and a 12 month high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $51.79 billion, a price-to-earnings ratio of 175.51, a price-to-earnings-growth ratio of 6.79 and a beta of 1.05. The company’s fifty day moving average price is $623.43 and its two-hundred day moving average price is $496.32.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. This trade represents a 8.77 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the transaction, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock worth $30,721,337 in the last ninety days. 6.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on AXON shares. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird increased their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. JMP Securities increased their price objective on shares of Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research report on Tuesday, February 4th. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Finally, The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $542.15.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.